The initiation of coverage by Goldman Sachs, a major investment bank, is a significant event for Klaviyo. The Neutral rating suggests that Goldman Sachs does not expect the stock to outperform the market in the short term. The price target of $36 provides a reference point for investors, but it does not necessarily imply a strong upside or downside.